Beatrix Bartók

Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy

Mark C. Genovese, Kenneth Kalunian, Jacques‐Eric Gottenberg et al. · JAMA · 2019 · 305 citations · Full text

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial

Bernard Combe, Alan Kivitz, Yoshiya Tanaka et al. · Annals of the Rheumatic Diseases · 2021 · 228 citations · Full text

Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial

René Westhovens, William F. C. Rigby, Désirée van der Heijde et al. · Annals of the Rheumatic Diseases · 2021 · 134 citations · Full text

PI3 Kinase δ Is a Key Regulator of Synoviocyte Function in Rheumatoid Arthritis

Beatrix Bartók, David L. Boyle, Yi Liu et al. · American Journal Of Pathology · 2012 · 107 citations · Full text

Inflammation, Rheumatology, Rheumatoid Disorder +13

Post-transcriptional Regulation of the Yeast High Affinity Iron Transport System

Maria Rosa Felice, Ivana De Domenico, Liangtao Li et al. · Journal of Biological Chemistry · 2005 · 98 citations · Full text

High Iron, Transcriptional Regulation, Biochemistry +15